The Human Cytomegalovirus UL51 Protein Is Essential for Viral Genome Cleavage-Packaging and Interacts with the Terminase Subunits pUL56 and pUL89
Eva Maria Borst,Jennifer Kleine-Albers,Ildar Gabaev,Marina Babić,Karen Wagner,Anne Binz,Inga Degenhardt,Markus Kalesse,Stipan Jonjić,Rudolf Bauerfeind,Martin Messerle +10 more
TLDR
Evidence is provided that pUL51 is crucial for HCMV genome cleavage-packaging and may represent a third component of the viral terminase complex, and interference with the interactions between the terminase subunits by antiviral drugs could be a strategy to disrupt the H CMV replication cycle.Abstract:
Cleavage of human cytomegalovirus (HCMV) genomes as well as their packaging into capsids is an enzymatic process mediated by viral proteins and therefore a promising target for antiviral therapy. The HCMV proteins pUL56 and pUL89 form the terminase and play a central role in cleavage-packaging, but several additional viral proteins, including pUL51, had been suggested to contribute to this process, although they remain largely uncharacterized. To study the function of pUL51 in infected cells, we constructed HCMV mutants encoding epitope-tagged versions of pUL51 and used a conditionally replicating virus (HCMV-UL51-ddFKBP), in which pUL51 levels could be regulated by a synthetic ligand. In cells infected with HCMV-UL51-ddFKBP, viral DNA replication was not affected when pUL51 was knocked down. However, no unit-length genomes and no DNA-filled C capsids were found, indicating that cleavage of concatemeric HCMV DNA and genome packaging into capsids did not occur in the absence of pUL51. pUL51 was expressed mainly with late kinetics and was targeted to nuclear replication compartments, where it colocalized with pUL56 and pUL89. Upon pUL51 knockdown, pUL56 and pUL89 were no longer detectable in replication compartments, suggesting that pUL51 is needed for their correct subnuclear localization. Moreover, pUL51 was found in a complex with the terminase subunits pUL56 and pUL89. Our data provide evidence that pUL51 is crucial for HCMV genome cleavage-packaging and may represent a third component of the viral terminase complex. Interference with the interactions between the terminase subunits by antiviral drugs could be a strategy to disrupt the HCMV replication cycle.read more
Citations
More filters
Journal ArticleDOI
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
Francisco M. Marty,Per Ljungman,Roy F. Chemaly,Johan Maertens,Sanjeet Dadwal,Rafael F. Duarte,Shariq Haider,Andrew J. Ullmann,Yuta Katayama,Janice M. Brown,Kathleen M. Mullane,Michael Boeckh,Emily A. Blumberg,Hermann Einsele,David R. Snydman,Yoshinobu Kanda,Mark J. DiNubile,Valerie L Teal,Hong Wan,Yoshihiko Murata,Nicholas A. Kartsonis,Randi Y. Leavitt,Cyrus Badshah +22 more
TL;DR: Letermovir prophylaxis resulted in a significantly lower risk of clinically significant CMV infection than placebo, and the frequency and severity of adverse events were similar in the two groups overall.
Journal ArticleDOI
Rapid in Vitro Evolution of Human Cytomegalovirus UL56 Mutations that Confer Letermovir Resistance
TL;DR: The multiplicity of pathways to high-grade LMV resistance with minimal viral growth impact suggests a low viral genetic barrier and the need for close monitoring during treatment of active infection.
Journal ArticleDOI
Mechanisms of DNA Packaging by Large Double-Stranded DNA Viruses
Venigalla B. Rao,Michael Feiss +1 more
TL;DR: Current focus is on the structures of packaging complexes and the dynamics of TerL during DNA packaging, endonuclease regulation, and motor mechanics.
Book ChapterDOI
Herpesvirus Capsid Assembly and DNA Packaging
TL;DR: A summary of recent advances with respect to the structure of the HSV-1 virion capsid and what is known about the function of the seven packaging proteins and their interactions with each other and with the capsid shell is presented.
Journal ArticleDOI
Cytomegalovirus Vaccines: Current Status and Future Prospects
TL;DR: An overview of HCMV vaccine candidates in various stages of development is provided, as well as an update on the current status of ongoing clinical trials.
References
More filters
Journal ArticleDOI
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
TL;DR: A simple and highly efficient method to disrupt chromosomal genes in Escherichia coli in which PCR primers provide the homology to the targeted gene(s), which should be widely useful, especially in genome analysis of E. coli and other bacteria.
Journal ArticleDOI
Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection.
TL;DR: Despite high seroprevalences in some populations, a substantial percentage of women of reproductive age are CMV seronegative and thus at risk of primary CMV infection during pregnancy, and future vaccine or educational campaigns to prevent primary infection in pregnant women may need to be tailored to suit the needs of different populations.
Journal ArticleDOI
A Rapid, Reversible, and Tunable Method to Regulate Protein Function in Living Cells Using Synthetic Small Molecules
Laura A. Banaszynski,Ling chun Chen,Lystranne A. Maynard-Smith,A. G.Lisa Ooi,Thomas J. Wandless +4 more
TL;DR: A general technique to regulate the stability of specific proteins in mammalian cells using cell-permeable, synthetic molecules and genetic fusion of the destabilizing domain to a gene of interest ensures specificity, and the attendant small-molecule control confers speed, reversibility, and dose-dependence to this method.
Journal ArticleDOI
Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli.
TL;DR: A procedure that combines Red recombination and cleavage with the homing endonuclease I-SceI to allow highly efficient, PCR-based DNA engineering without retention of unwanted foreign sequences is described.
Journal ArticleDOI
Functional profiling of a human cytomegalovirus genome
Walter Dunn,Cassie Chou,Hong Li,Rong Hai,David A. Patterson,Viktor Stolc,Hua Zhu,Fenyong Liu +7 more
TL;DR: HCMV encodes supportive and suppressive growth regulators for optimizing its replication in human fibroblasts, epithelial, and endothelial cells, and may contribute to HCMV's optimal infection of different tissues and successful proliferation among the human population.
Related Papers (5)
Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation
Roy F. Chemaly,Andrew J. Ullmann,Susanne Stoelben,Marie Paule Richard,Martin Bornhäuser,Christoph Groth,Hermann Einsele,Margarida Silverman,Kathleen M. Mullane,Janice M. Brown,Horst Nowak,Katrin Kol̈ling,Hans Peter Stobernack,Peter Lischka,Holger Zimmermann,Helga Rübsamen-Schaeff,Richard E. Champlin,Gerhard Ehninger +17 more